Test Module 2

Today Dr Tedros Adhanom Ghebreyesus, WHO Director-General, and Dr Ursula von der Leyen, President of the European Commission, co-hosted the inaugural meeting of the Access to COVID-19 Tools (ACT) Accelerator Facilitation Council.

Roles: Everyone: All Users

Regions: Canada , China, France , Italy , Norway , Rwanda , South Africa , United Kingdom , Uzbekistan

Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health

• Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
  
• 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

  Roles: Everyone: All Users

  Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

  Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• INFOSAN Quarterly Summary, 2020 #2

  During the second quarter of 2020, the INFOSAN Secretariat has been involved in 29 food safety incidents with 59 WHO Member States and two territories of WHO Member States. There were 13 biological hazard incidents (Salmonella [5], Listeria monocytogenes [3], Clostridium botulinum [2], Vibrio cholerae [1], and two involving an unspecified biological hazard), six with a chemical hazard (methanol [3], histamine [2] and patulin [1]), five involving an undeclared allergen (cashew and pistachio [1], sesame [1],

  Roles: Everyone: All Users

  Regions: Australia , Cambodia , Canada , China, Dominican Republic , France , Hong Kong , Mexico , Singapore , United States

  Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Energy, Global Health

• Public statement for collaboration on COVID-19 vaccine development

  Roles: Everyone: All Users

  Regions: Argentina, Canada , Chad , China, Norway , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

• WHO Timeline - COVID-19

  Roles: Everyone: All Users

  Regions: Canada , China, Singapore , United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

• Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020

  Roles: Everyone: All Users

  Regions: China

  Topics: Coronavirus (COVID-19), Global Health